A comparative study on the effect of streptokinase between diabetic and non-diabetic myocardial infarction patients 1

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction With ST-Segment ElevationSabatine MS, for the CLARITY-TIMI 28 Investigators (Harvard Med School, Boston; et al) N Engl J Med 352:1179-1189, 2005§

  2006cited by this paper
• Comparative analysis of the activity and content of different streptokinase preparations.

  2005cited by this paper
• Implementation of reperfusion therapy in acute myocardial infarction. A policy statement from the European Society of Cardiology.

  2005cited by this paper
• Comparison of pre-hospital combination-fibrinolysis plus conventional care with pre-hospital combination-fibrinolysis plus facilitated percutaneous coronary intervention in acute myocardial infarction.

  2005influential reference
• Diabetes mellitus: the major risk factor in unstable coronary artery disease even after consideration of the extent of coronary artery disease and benefits of revascularization.

  2004cited by this paper
• Type 2 diabetes and intravenous thrombolysis outcome in the setting of ST elevation myocardial infarction.

  2004influential reference
• Impact of diabetes mellitus on epicardial and microvascular flow after fibrinolytic therapy.

  2002influential reference
• ST-elevation myocardial infarction.

  2002cited by this paper
• What's the point of ST elevation?

  2002cited by this paper
• Time to Treatment Influences the Impact of ST-Segment Resolution on One-Year Prognosis: Insights From the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Trial

  2001cited by this paper
• Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies.

  2001cited by this paper
• Non-invasive detection of early infarct vessel patency by resolution of ST-segment elevation in patients with thrombolysis for acute myocardial infarction; results of the angiographic substudy of the Hirudin for Improvement of Thrombolysis (HIT)-4 trial.

  2001cited by this paper
• Impact of diabetes mellitus on long term survival after acute myocardial infarction in patients with single vessel disease

  2001influential reference
• Emergency management of acute myocardial infarction.

  1999cited by this paper
• Influence of Diabetes Mellitus on Clinical Outcome in the Thrombolytic Era of Acute Myocardial Infarction

  1997influential reference
• The Blood Contribution to Early Myocardial Reperfusion Injury Is Amplified in Diabetes

  1997cited by this paper
• Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction. Zwolle Myocardial infarction Study Group.

  1997cited by this paper
• Change in ST segment elevation 60 minutes after thrombolytic initiation predicts clinical outcome as accurately as later electrocardiographic changes

  1997cited by this paper
• Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience.

  1996cited by this paper
• Ability of the no-reflow phenomenon during an acute myocardial infarction to predict left ventricular dysfunction at one-month follow-up.

  1995cited by this paper
• Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction.

  1994cited by this paper

• No citing papers are available for this paper.